Aurinia Pharm Ord (AUPH) Stock Price, Quote & News

Company Profile

Aurinia Pharmaceuticals Inc. is a biopharmaceutical company that engages in delivering therapies to people living with autoimmune diseases with high unmet medical needs. It offers LUPKYNIS (voclosporin), an oral therapy for the treatment of adult patients with active lupus nephritis. The company also develops AUR200, a dual inhibitor of B cell activating factor and a proliferation inducing ligand for the potential treatment of autoimmune diseases. It has a collaboration and license agreement wit...

Industry: Biotechnology

Sector: Healthcare

Phone: 250 744 2487

Fax: 250 708 4345

Website: www.auriniapharma.com

Address:

#140, 14315 – 118 Avenue, Edmonton, Canada

joemist1 Jul. 17 at 8:49 AM

$AUPH Can we all go to church and pray that the pig dies. Amen

0 · Reply

Toni19 Jul. 17 at 7:09 AM

$AUPH Very good possible, with your bo scenario, because if we look, that ALPINE get a bo just with the beginning with the P2 for 4.9 billion dollar!🤷‍♂️But,....we have a drug calling Lupkynis, for now, a 250 million dollar drug, CFP and over 300 million dollar in cash! Just think about for a minute!🤗

0 · Reply

DARK_MAGA_SCROOGIE Jul. 17 at 3:54 AM

$AUPH trash just like dorkpicks LOL

0 · Reply

Yarrow Jul. 17 at 3:11 AM

$AUPH Dont let her fool ya.

0 · Reply

Hopenitsgood Jul. 17 at 1:44 AM

$AUPH When shitlysta started doing commercials for not only for Lupus but also lupus nephritis (just saw another one grace my tv) it should have been known that Peter......is a dick.

0 · Reply

Hopenitsgood Jul. 17 at 1:22 AM

$AUPH This thing hit $8.50 EIGHT years ago! Peter Greenleaf is a criminal and deserves worse than an acid bath. The BODs are no less criminal. Whetr atee the class action lawsuits? Where are the eulogies?

0 · Reply

therightpicks Jul. 17 at 1:04 AM

$AUPH So basically, PG and the BOD, once again has screwed us retail longs. What a fucking bunch of pricks!!!

1 · Reply

BillyRayValentine7 Jul. 17 at 12:18 AM

$AUPH what is going on now? Can't I just enjoy a night. Internet sucks. The invention of it is worse things to mankind .

0 · Reply

teamgreen Jul. 16 at 9:50 PM

$AUPH only when i see a lot of shares granted, gl

0 · Reply

Auphiliate Jul. 16 at 9:46 PM

$AUPH So they ran it up for a mini bull trap this AM? 😂

0 · Reply

The Play On Aurinia Pharmaceuticals: Rising Cash Flow Provides Opportunity

Jun 30, 2025, 6:00 AM EDT - 16 days ago

Aurinia Announces Positive Results from Phase 1 Study of Aritinercept (AUR200)

Jun 29, 2025, 5:00 PM EDT - 17 days ago

Aurinia Pharmaceuticals to Host Conference Call to Discuss AUR200 Phase 1 Study Results on June 30, 2025

May 22, 2025, 6:00 AM EDT - 7 weeks ago

New AURORA 1 Analysis: LUPKYNIS-Based Triple Immunosuppressive Therapy Yields Deep Proteinuria Reduction in Lupus Nephritis

May 12, 2025, 12:56 PM EDT - 2 months ago

Aurinia Pharma Swings Into Profit As Q1 Sales Jumps 24%, Sticks To Guidance

May 12, 2025, 11:04 AM EDT - 2 months ago

Aurinia Pharmaceuticals Inc. (AUPH) Q1 2025 Earnings Call Transcript

May 12, 2025, 6:00 AM EDT - 2 months ago

Aurinia Pharmaceuticals Reports Financial Results for the Three Months Ended March 31, 2025

May 5, 2025, 6:00 AM EDT - 2 months ago

Aurinia Pharmaceuticals to Release First Quarter 2025 Financial and Operational Results on May 12, 2025

Apr 30, 2025, 6:00 AM EDT - 2 months ago

Glass Lewis Recommends That Aurinia Shareholders Vote “FOR” All Proposals at 2025 Annual General Meeting

Apr 29, 2025, 6:00 AM EDT - 2 months ago

ISS Recommends That Aurinia Shareholders Vote “FOR” All Proposals at 2025 Annual General Meeting

Apr 26, 2025, 10:54 AM EDT - 2 months ago

Aurinia Pharmaceuticals: Shareholder Pressure And Sales Growth

Apr 23, 2025, 4:05 PM EDT - 3 months ago

Concerned Shareholders of Aurinia Pharmaceuticals Announce Their Intention to Withhold Support for CEO Peter Greenleaf at 2025 Annual Meeting

Feb 27, 2025, 2:11 PM EST - 4 months ago

Autoimmune Disease-Focused Aurinia Pharmaceuticals Reports Quarterly Profit, Revenue Outlook Below Expectations

Feb 27, 2025, 10:32 AM EST - 4 months ago

Aurinia Pharmaceuticals Inc. (AUPH) Q4 2024 Earnings Call Transcript

Feb 27, 2025, 6:00 AM EST - 4 months ago

Aurinia Pharmaceuticals Reports Financial Results for the Three and Twelve Months Ended December 31, 2024 and Provides Update on Recent Corporate Progress

Feb 21, 2025, 4:09 PM EST - 5 months ago

Aurinia Pharmaceuticals: There's Still Time For Sales Growth

Feb 20, 2025, 4:05 PM EST - 5 months ago

Aurinia Pharmaceuticals to Release 2024 Fourth Quarter and Full Year Financial and Operational Results on February 27, 2025

Jan 22, 2025, 12:29 PM EST - 6 months ago

3 Biotech Stocks With Notable Insider Buying

AZN COGT JAZZ ONC XBI ZYME

Nov 18, 2024, 5:53 PM EST - 8 months ago

Aurinia Commends 2024 Updated ACR Guidelines for Screening, Treatment, and Management of Lupus Nephritis

Nov 15, 2024, 6:00 AM EST - 8 months ago

Aurinia Presents New Data Underscoring Critical Importance of Earlier Lupus Nephritis Detection and Intervention and Value of LUPKYNIS® in Managing LN at American College of Rheumatology Convergence 2024

Nov 14, 2024, 6:00 AM EST - 8 months ago

Aurinia to Participate in Jefferies London Healthcare Conference

Nov 8, 2024, 12:15 PM EST - 8 months ago

Aurinia Pharmaceuticals: A Potential Buyout Looms On The Horizon

Nov 7, 2024, 11:44 AM EST - 8 months ago

Aurinia Pharmaceuticals, Inc. (AUPH) Q3 2024 Earnings Call Transcript

Nov 7, 2024, 6:10 AM EST - 8 months ago

Aurinia Pharmaceuticals Appoints Craig Johnson to Board of Directors to Support Next Phase of Growth

Nov 7, 2024, 6:00 AM EST - 8 months ago

Aurinia Pharmaceuticals Reports Third Quarter and Nine Months 2024 Financial and Operational Results, Announces Strategic Restructuring to Sharpen Focus on Continued LUPKYNIS® Growth and AUR200 Development

Oct 30, 2024, 4:05 PM EDT - 9 months ago

Aurinia Pharmaceuticals to Release Third Quarter Financial and Operational Results on November 7, 2024

Oct 11, 2024, 6:00 AM EDT - 9 months ago

Aurinia Presents New Data Highlighting Real-World Utilization and Value of LUPKYNIS® in Treating Lupus Nephritis at American Society of Nephrology Kidney Week 2024

Sep 24, 2024, 8:10 AM EDT - 10 months ago

Aurinia Announces Japan Approval of LUPKYNIS® (Voclosporin) to Treat Lupus Nephritis

Sep 19, 2024, 12:54 PM EDT - 10 months ago

3 Small Biotech Stocks With The 'Big Mo' Right Now

CORT VRDN

Sep 19, 2024, 7:55 AM EDT - 10 months ago

Aurinia Pharmaceuticals: LUPKYNIS Leading The Way In Lupus Nephritis Treatment

Sep 18, 2024, 4:41 AM EDT - 10 months ago

Aurinia Pharmaceuticals: This Recovery Can Continue

Sep 13, 2024, 6:00 AM EDT - 10 months ago

Aurinia to Participate in 2024 Cantor Fitzgerald Global Healthcare Conference

Sep 12, 2024, 4:05 PM EDT - 10 months ago

Aurinia Announces Board Restructuring

Sep 5, 2024, 6:00 AM EDT - 11 months ago

Aurinia Announces First Participant Dosed in AUR200 Single Ascending Dose Trial

Aug 28, 2024, 6:00 AM EDT - 11 months ago

Aurinia to Participate in H.C. Wainwright 26th Annual Global Investment Conference

Aug 13, 2024, 8:00 AM EDT - 1 year ago

Aurinia Pharmaceuticals Shareholder Calls for CEO Peter Greenleaf, Dr. Brinda Balakrishnan, and Dr. Robert Foster to Resign from the Board

Aug 1, 2024, 1:52 PM EDT - 1 year ago

Aurinia Pharmaceuticals, Inc. (AUPH) Q2 2024 Earnings Call Transcript

Aug 1, 2024, 6:00 AM EDT - 1 year ago

Aurinia Pharmaceuticals Reports Second Quarter and Six Months 2024 Financial and Operational Results

Jul 19, 2024, 6:00 AM EDT - 1 year ago

Aurinia Pharmaceuticals to Release Second Quarter Financial and Operational Results on August 1, 2024

Jul 11, 2024, 3:27 PM EDT - 1 year ago

ILJIN SNT Co., Ltd. Calls on Board of Aurinia Pharmaceuticals to Honor Shareholders' Voices Expressed at the AGM

Jul 5, 2024, 2:10 PM EDT - 1 year ago

Aurinia Pharmaceuticals Appears Undervalued

Jul 2, 2024, 6:00 AM EDT - 1 year ago

Aurinia to Participate in Upcoming Investor Healthcare Conferences

Jun 14, 2024, 12:16 PM EDT - 1 year ago

Aurinia Announces 2024 Annual General Meeting Results

Jun 5, 2024, 6:00 AM EDT - 1 year ago

Aurinia Presents Safety and Efficacy Profile of LUPKYNIS® for People with Lupus Nephritis at European Alliance of Associations for Rheumatology (EULAR) Congress 2024

Jun 4, 2024, 5:30 PM EDT - 1 year ago

Aurinia Addresses Dubious Proposals Put Forth by Lucien Selce

Jun 3, 2024, 6:30 PM EDT - 1 year ago

Aurinia Provides Update on Proxy Statement

Jun 3, 2024, 8:00 AM EDT - 1 year ago

Aurinia Pharmaceuticals Shareholder Urges Fellow Shareholders to Withhold Support for CEO Peter Greenleaf

Jun 2, 2024, 10:18 AM EDT - 1 year ago

3 Biotech Names Under $10 I Own

FOLD VYGR

May 30, 2024, 6:00 AM EDT - 1 year ago

Aurinia Will Attend 2024 Jefferies Global Healthcare Conference

May 14, 2024, 6:00 AM EDT - 1 year ago

Analysis Showing LUPKYNIS® is a Cost-Effective Treatment for Lupus Nephritis Presented at National Kidney Foundation's Spring Clinical Meeting 2024

joemist1 Jul. 17 at 8:49 AM

$AUPH Can we all go to church and pray that the pig dies. Amen

0 · Reply

Toni19 Jul. 17 at 7:09 AM

0 · Reply

DARK_MAGA_SCROOGIE Jul. 17 at 3:54 AM

$AUPH trash just like dorkpicks LOL

0 · Reply

Yarrow Jul. 17 at 3:11 AM

$AUPH Dont let her fool ya.

0 · Reply

Hopenitsgood Jul. 17 at 1:44 AM

$AUPH When shitlysta started doing commercials for not only for Lupus but also lupus nephritis (just saw another one grace my tv) it should have been known that Peter......is a dick.

0 · Reply

Hopenitsgood Jul. 17 at 1:22 AM

0 · Reply

therightpicks Jul. 17 at 1:04 AM

$AUPH So basically, PG and the BOD, once again has screwed us retail longs. What a fucking bunch of pricks!!!

1 · Reply

BillyRayValentine7 Jul. 17 at 12:18 AM

$AUPH what is going on now? Can't I just enjoy a night. Internet sucks. The invention of it is worse things to mankind .

0 · Reply

teamgreen Jul. 16 at 9:50 PM

$AUPH only when i see a lot of shares granted, gl

0 · Reply

Auphiliate Jul. 16 at 9:46 PM

$AUPH So they ran it up for a mini bull trap this AM? 😂

0 · Reply

Iwillplay Jul. 16 at 8:43 PM

$AUPH Never fails to disappoint. Give PG, BODs and all who voted to keep these POSs there, a big...

1 · Reply

zerotomil Jul. 16 at 8:19 PM

$AUPH Yay! Hashtagzee upgrade from $5 to $7

0 · Reply

Gamaret Jul. 16 at 8:17 PM

$AUPH It was nice $9.19, but it didn't last long

1 · Reply

albertop Jul. 16 at 7:58 PM

$AUPH And I was completely wrong! F this stock! Hopefully a better day tomorrow.

0 · Reply

hashtagzee Jul. 16 at 7:03 PM

$AUPH Being temporarily propped up to eventually reel in new bagholders. Once they announce any form of additional investments into AUR200, this sinks back down to $7.

1 · Reply